Embring, A.; Onjukka, E.; Mercke, C.; Lax, I.; Berglund, A.; Friesland, S.
Dose Escalation of Oropharyngeal Cancer: Long-Time Follow-Up and Side Effects. Cancers 2023, 15, 2580.
https://doi.org/10.3390/cancers15092580
AMA Style
Embring A, Onjukka E, Mercke C, Lax I, Berglund A, Friesland S.
Dose Escalation of Oropharyngeal Cancer: Long-Time Follow-Up and Side Effects. Cancers. 2023; 15(9):2580.
https://doi.org/10.3390/cancers15092580
Chicago/Turabian Style
Embring, Anna, Eva Onjukka, Claes Mercke, Ingmar Lax, Anders Berglund, and Signe Friesland.
2023. "Dose Escalation of Oropharyngeal Cancer: Long-Time Follow-Up and Side Effects" Cancers 15, no. 9: 2580.
https://doi.org/10.3390/cancers15092580
APA Style
Embring, A., Onjukka, E., Mercke, C., Lax, I., Berglund, A., & Friesland, S.
(2023). Dose Escalation of Oropharyngeal Cancer: Long-Time Follow-Up and Side Effects. Cancers, 15(9), 2580.
https://doi.org/10.3390/cancers15092580